Iron-deficiency anemia is a common complication of chronic kidney disease (CKD). It happens when your body doesn't have enough iron. You need iron to make the protein hemoglobin, which helps your red ...
India Today on MSN
US approves first pill for thalassemia anemia: What this means for India
The US FDA has approved mitapivat, the first oral medicine for treating anemia caused by thalassemia. At present, mitapivat ...
Approval was based on the phase 3 ENERGIZE and ENERGIZE-T studies evaluating the safety and efficacy of mitapivat in adults with alpha- or beta-thalassemia.
Health on MSN
10 Health Conditions Iron Can Help Improve Naturally
The body needs iron to deliver oxygen throughout the body. Iron supplements can help improve many conditions, such as anemia ...
MedPage Today on MSN
FDA Approves Mitapivat for Thalassemia-Related Anemia
An oral pyruvate kinase (PK) activator, mitapivat becomes the only approved option for treating anemia in both ...
While anemia is not a typical symptom of IBS, people with IBS may develop anemia if they cannot absorb enough iron from their food. Irritable bowel syndrome (IBS) is a common gastrointestinal disorder ...
Hosted on MSN
Anemia of Chronic Disease: What to Know
Anemia of chronic disease is anemia caused by inflammation from a long-term or chronic illness. It is also called anemia of inflammation. People with anemia of chronic disease may have normal or even ...
Anemia in babies may manifest as pale skin, irritability, and a fast heart rate. Sometimes, mild to moderate anemia may not produce symptoms, but severe anemia can have very serious consequences. A ...
Anemia, when levels of RBCs are low typically due to an iron deficiency, may cause headaches or migraine episodes. There are therapies to manage headaches and options to treat anemia. Anemia is a ...
Leuven, Belgium − Many patients with a chronic disease or cancer have to contend with anemia − and the severe fatigue that accompanies anemia impedes the patient considerably in his or her daily ...
The biopharmaceutical company said Tuesday that Aqvesme is now the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia.
Agios Pharmaceuticals has announced a major regulatory milestone with the U.S. Food and Drug Administration approving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results